An article from International, excerpt, please read the whole article :
" NEW DELHI, Aug 23 : Howls of protest from doctors and officials in India have followed the naming of the New Delhi Metallo-1 (NDM-1), a gene that can transform infectious bacteria into superbugs that are resistant to the most powerful antibiotics. But other experts hope that the furore on this issue may lead to a rethink on the widespread practice of using medicines indiscriminately.
A joint Indo-British study published in the Aug. 11 issue of the prestigious medical journal Lancet Infectious Diseases links the entry of the NDM-1 gene into Britain with patients who availed of treatment in Indian and Pakistani hospitals. The protests from the union health ministry as well as representatives of India's medical tourism industry -- that attracts four million foreign patients a year and is estimated to be worth 3 billion dollars -- are primarily directed at the gene being named after the Indian capital.
''While the title and the contents (of the Lancet article) broadly describe the antibiotics resistance profile of gram negative bacteria and its mechanism due to NDM-1... the conclusions are loaded with the inference that these (resistant genes) possibly originated in India and it may not be safe for UK patients to opt for surgery in India,'' a health ministry statement said."
No comments:
Post a Comment